drugset / Trial / NCT00022139

Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

NCT00022139 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy, such as paclitaxel, carboplatin, and fluorouracil, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving radiation therapy with chemotherapy and giving them before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: This phase II trial is studying how well giving radiation therapy together with combination chemotherapy followed by esophagectomy works in treating patients with locally advanced cancer of the esophagus or gastroesophageal junction.

Timeline

Start
2002-01
Primary completion
2005-07
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 4 unknown Intravenous
Subject Paclitaxel Small molecule 200 mg/m2 Intravenous
Subject fluorouracil Small molecule 225 mg/m2 Intravenous